COL10A1表达区分高危基底细胞癌间质中的癌症相关成纤维细胞亚群
该研究通过激光捕获显微切割联合RNA测序分析五种纯亚型基底细胞癌(BCC)间质,发现不同亚型间质基因表达特征各异;COL10A1在硬化型/浸润型和基底鳞状型等高危亚型间质中过表达,并由特定癌症相关成纤维细胞(CAF)亚群表达,提示其可作为BCC进展的预后标志物。
要点
- 不同BCC亚型间质基因表达特征存在差异,结节型与微结节型最相似。
- COL10A1在硬化型/浸润型和基底鳞状型BCC间质中过表达。
- COL10A1由浸润性BCC邻近间质中的特定CAF亚群表达。
核心结论
- COL10A1是高危BCC(尤其硬化型/浸润型和基底鳞状型)间质的标志物,由特定CAF亚群表达,提示其作为BCC进展的预后生物标志物。
研究设计与样本
- 研究在93例不同BCC和13例健康皮肤样本中通过IHC验证发现,并利用两个独立公共单细胞RNA-Seq数据集和RNAscope进行验证。
主要发现
- 不同BCC亚型间质具有 distinct 基因表达特征,结节型与微结节型最相似,浅表型与硬化型差异最大。
- COL10A1在硬化型/浸润型和基底鳞状型BCC间质中过表达,但在微结节型高危亚型中未过表达。
- 单细胞RNA-Seq分析显示COL10A1表达细胞群与浸润性BCC邻近间质相关,并具有细胞外基质重塑特征。
临床怎么用
- COL10A1表达可能有助于识别高危BCC亚型(硬化型/浸润型和基底鳞状型),辅助预后评估。
- 靶向COL10A1阳性CAF亚群或间质微环境可能为BCC提供新的个体化治疗策略。
局限性
- COL10A1在BCC进展中的功能机制尚未明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Basal cell carcinoma (BCC) is the most frequently diagnosed skin cancer and the most common malignancy in humans. Different morphological subtypes of BCC are associated with a low or high risk of recurrence and aggressiveness, but the underlying biology of how the individual subtypes arise remains largely unknown. As the majority of BCCs appear to arise from mutations in the same pathway, we hypothesized that BCC development, growth and invasive potential is also influenced by the tumour microenvironment and, in particular, by cancer-associated fibroblasts (CAFs) and the factors they secrete. OBJECTIVES: To characterize the stroma of the different BCC subtypes with a focus on CAF populations. METHODS: To investigate the stromal features of the different BCC subtypes, we used laser capture microdissection (LCM) followed by RNA sequencing (RNA-Seq). Fifteen BCC samples from five different 'pure' subtypes (i.e. superficial, nodular, micronodular, sclerosing and basosquamous; n = 3 each) were selected and included in the analysis. Healthy skin was used as a control (n = 6). The results were confirmed by immunohistochemistry (IHC). We validated our findings in two independent public single-cell RNA-Seq (scRNA-Seq) datasets and by RNAscope. RESULTS: The stroma of the different BCC subtypes were found to have distinct gene expression signatures. Nodular and micronodular appeared to have the most similar signatures, while superficial and sclerosing the most different. By comparing low- and high-risk BCC subtypes, we found that COL10A1 is overexpressed in the stroma of sclerosing/infiltrative and basosquamous but not in micronodular high-risk subtypes. Those findings were confirmed by IHC in 93 different BCC and 13 healthy skin samples. Moreover, scRNA-Seq analysis of BCCs from two independent datasets found that the COL10A1-expressing population of cells is associated with the stroma adjacent to infiltrative BCC and shows extracellular matrix remodelling features. CONCLUSIONS: We identified COL10A1 as a marker of high-risk BCC, in particular of the sclerosing/infiltrative and basosquamous subtypes. We demonstrated at the single-cell level that COL10A1 is expressed by a specific CAF population associated with the stroma of infiltrative BCC. This opens up new, tailored treatment options, and suggests COL10A1 as a new prognostic biomarker for BCC progression. Basal cell carcinoma (‘BCC’ for short) is the most common type of cancer in humans. BCC occurs when a certain type of skin cell transforms in the outermost layer of the skin. This is mostly caused by a lot of exposure to sunlight. BCC can appear in different forms, or ‘subtypes’. In each subtype, cancer cells grow in a specific way and are visually distinct from the surrounding tissue, known as the ‘stroma’. The different subtypes of BCC can have a low or high risk of cancer recurrence and different levels of aggressiveness. We aimed to find out what the stroma is made up of in the different subtypes of BCC, focusing on the differences between low-risk and high-risk cancers. We measured gene expression in specific areas of tissue and identified one gene called ‘COL10A1’ as being overexpressed in the stroma of high-risk BCC, especially in two particular subtypes (‘sclerosing’ and ‘basosquamous’ BCC). We confirmed this result in BCC biopsies. We also checked other published data and found that COL10A1 is mostly expressed in a type of cell called a ‘fibroblast’. Fibroblasts expressing the COL10A1 gene are present in the stroma right beside the infiltrative area of BCC. Our findings could be used to develop more personalized treatment of BCC. The stroma may be a potential anti-cancer target, as well as a new way of testing for BCC progression.
引用
- Esposito M, Yerly L, Shukla P, et al. COL10A1 expression distinguishes a subset of cancer-associated fibroblasts present in the stroma of high-risk basal cell carcinoma. Br J Dermatol. 2024. PMID: 38916477. doi:10.1093/bjd/ljae258
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。